The negative findings from the G.D. Searle and Industrial Bio-Test Laboratories (IBT) cases revealed:

• A. A wide range of uncontrolled, unsupervised study and facility operations including major lapses in the integrity of data scientific practices
• B. Perfect adherence to protocols
• C. No issues with data handling
• D. Only minor administrative errors

Answer: (A)

In GLP, credible regulatory data depend on proper supervision, strict adherence to protocols, and complete, traceable records. The negative findings from the G.D. Searle and Industrial Bio-Test Laboratories cases showed widespread failures in those areas. There were uncontrolled, unsupervised study and facility operations, along with major lapses in data integrity and the scientific practices used to generate and report results. In other words, studies were not adequately overseen, essential steps and documentation were missing or unreliable, and data could not be trusted. This underscores why GLP emphasizes rigorous supervision, documented procedures, quality assurance oversight, and complete data trails. The other options describe perfect adherence or only minor issues, which does not reflect what these investigations uncovered.